Navigation path

Pharmaceuticals - Union Register


Register of orphan medicinal products


Product information

Human heterologous liver cells (for infusion)

EU orphan designation number: EU/3/10/818   
Active ingredient: Human heterologous liver cells (for infusion)
Indication: Treatment of citrullinaemia type 1
Sponsor: Promethera Biosciences
Watson & Crick Hill, 11 Rue Granbonpré, 1435 Mont-Saint-Guibert, Belgique

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
22/12/2010 Orphan designation EMA/OD/105/10 (2010)9531 of 17/12/2010
20/06/2016 Transfer of orphan designation EMA/OD/105/10/T/01 (2016)3850 of 16/06/2016